Participants' perspectives on safety monitoring in clinical trials

Clinical Trials

Volumn 10, Issue 4, 2013, Pages 552-559

  Flynn, Kathryn E ^a,b,c   Kramer, Judith M ^a,b   Dombeck, Carrie B ^a   Weinfurt, Kevin P ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; REVIEW; RISK ASSESSMENT;

ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; PATIENT SAFETY; QUALITATIVE RESEARCH; RESEARCH SUBJECTS; SAFETY MANAGEMENT;

EID: 84881065931     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513484394     Document Type: Review

References (17)

1. Code of Federal Regulations. Title 21: Food and Drugs, Chapter 1: Food and Drug Administration, Department of Health and Human Services, Subchapter D: Drugs for Human Use, Part 312: Investigational New Drug Application, Subpart B: Investigational New Drug Application (IND). Sec. 312.32 IND safety reports 2010. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?fr=312.32
2. Office for Human Research Protections. Guidance on reviewing and reporting unanticipated problems involving risks to subjects or others and adverse events 2007. Available at: http://www.hhs.gov/ohrp/policy/advevntguid. html (accessed 24 October 2012).
3. US Food and Drug Administration. Guidance for clinical investigators, sponsors, and IRBs: Adverse event reporting to IRBs - Improving human subject protection 2009. Available at: http://www.fda.gov/downloads/ RegulatoryInformation/Guidances/UCM126572.pdf (accessed 24 October 2012).
4. The European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use 2001. Available at: http://www.eortc.be/services/doc/clinical-eu-directive-04-april-01.pdf (accessed 24 October 2012).
5. Dixon-Woods M, Tarrant C. Why do people cooperate with medical research? Findings from three studies. Soc Sci Med. 2009 ; 68 (12). 2215-22
6. Robinson EJ, Kerr C, Stevens A, et al. Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials. Soc Sci Med. 2004 ; 58 (4). 811-24
7. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA. 2004 ; 292 (13). 1593-601
8. Falagas ME, Korbila IP, Giannopoulou KP, Kondilis BK, Peppas G. Informed consent: How much and what do patients understand?. Am J Surg. 2009 ; 198 (3). 420-35
9. Weinfurt KP, Friedman JY, Allsbrook JS, et al. Views of potential research participants on financial conflicts of interest: Barriers and opportunities for effective disclosure. J Gen Intern Med. 2006 ; 21 (9). 901-06
10. Weinfurt KP, Hall MA, Dinan MA, et al. Effects of disclosing financial interests on attitudes toward clinical research. J Gen Intern Med. 2008 ; 23 (6). 860-66
11. Weinfurt KP, Hall MA, King NM, et al. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009 ; 361 (9). 916-21
12. Breitkopf CR, Loza M, Vincent K, et al. Perceptions of reimbursement for clinical trial participation. J Empir Res Hum Res Ethics. 2011 ; 6 (3). 31-38
13. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research?. PLoS Med. 2006 ; 3 (2). e19
14. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR. Race and trust in the health care system. Public Health Rep. 2003 ; 118 (4). 358-65
15. Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed-consent forms as compared with actual readability. N Engl J Med. 2003 ; 348 (8). 721-26
16. Albala I, Doyle M, Appelbaum PS. The evolution of consent forms for research: A quarter century of changes. IRB. 2010 ; 32 (3). 7-11
17. Menikoff J, Richards E What the Doctor Didn't Say: The Hidden Truth about Medical Research. Menikoff J Richards E, ed. New York: Oxford University Press ; 2006: 113-23.